Full text is available at the source.
Microbiota–gut–brain axis and probiotics: potential therapeutic strategies for treating Alzheimer’s disease
Gut bacteria and probiotics as possible treatments for Alzheimer's disease
AI simplified
Abstract
Changes in the intestinal microbiota may influence Alzheimer's disease through various biochemical mechanisms.
- Short-chain fatty acids produced by the gut microbiome regulate gut and blood-brain barrier permeability.
- These fatty acids may upregulate brain-derived neurotrophic factor and promote the growth of new blood vessels and neurons.
- They are associated with the regulation of tau and Aβ proteins, microglial activity, and neuroinflammation.
- Cognitive impairment is linked to low levels of specific gut microbiota in individuals with mild cognitive impairment and Alzheimer's disease.
- Certain bacterial species may improve cognitive function in affected individuals.
- Further longitudinal studies are necessary to explore precision medicine for patients with gut microbiota imbalances in early stages of Alzheimer's.
AI simplified